ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 95 filers reported holding ENZO BIOCHEM INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $66,000 | -34.0% | 24,225 | 0.0% | 0.00% | – |
| Q4 2018 | $100,000 | 0.0% | 24,225 | 0.0% | 0.00% | – |
| Q3 2018 | $100,000 | +9900.0% | 24,225 | +10861.5% | 0.00% | – |
| Q2 2018 | $1,000 | -50.0% | 221 | -45.4% | 0.00% | – |
| Q1 2018 | $2,000 | -96.4% | 405 | -94.1% | 0.00% | – |
| Q4 2017 | $56,000 | -37.1% | 6,827 | -19.7% | 0.00% | – |
| Q3 2017 | $89,000 | +36.9% | 8,507 | +44.9% | 0.00% | – |
| Q2 2017 | $65,000 | +71.1% | 5,872 | +30.2% | 0.00% | – |
| Q1 2017 | $38,000 | +15.2% | 4,511 | -5.9% | 0.00% | – |
| Q4 2016 | $33,000 | +43.5% | 4,793 | +7.2% | 0.00% | – |
| Q3 2016 | $23,000 | +21.1% | 4,470 | +36.9% | 0.00% | – |
| Q2 2016 | $19,000 | +216.7% | 3,265 | +156.9% | 0.00% | – |
| Q1 2016 | $6,000 | +500.0% | 1,271 | +788.8% | 0.00% | – |
| Q4 2015 | $1,000 | – | 143 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARBERT FUND ADVISORS, INC. | 5,169,337 | $17,420,000 | 25.49% |
| Roumell Asset Management, LLC | 1,236,309 | $4,166,000 | 9.86% |
| Evermore Global Advisors, LLC | 3,587,251 | $12,089,000 | 2.28% |
| CORRADO ADVISORS, LLC | 198,544 | $669,000 | 0.60% |
| Fondren Management LP | 175,863 | $593,000 | 0.56% |
| MARATHON CAPITAL MANAGEMENT | 247,130 | $832,000 | 0.34% |
| KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $322,000 | 0.21% |
| EAM Investors, LLC | 178,939 | $603,000 | 0.15% |
| Leap Investments LP | 11,811 | $40,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 75,900 | $256,000 | 0.03% |